• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090

Introduction to 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic Acid (CAS No: 1261898-31-0)

3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. With the CAS number 1261898-31-0, this compound represents a unique structural motif that combines a benzoic acid core with functional groups such as a carboxylic acid and a nitro group, further modified by a fluorophenyl substituent. The presence of these functional groups not only imparts distinct chemical properties but also opens up a wide array of potential applications in drug discovery and synthesis.

The benzoic acid backbone is a well-documented scaffold in medicinal chemistry, known for its versatility in forming hydrogen bonds and its role as an intermediate in the synthesis of various bioactive molecules. The introduction of a carboxy group at the 3-position enhances the compound's solubility in polar solvents, making it more amenable for biological assays and formulation development. Additionally, the fluorine atom at the 5-position of the phenyl ring introduces electronic and steric effects that can modulate the compound's interactions with biological targets.

The nitro group at the 5-position of the benzoic acid ring is another critical feature that influences the compound's reactivity and pharmacological profile. Nitroaromatic compounds are widely studied due to their potential as intermediates in drug synthesis and their ability to act as prodrugs or direct-acting therapeutics. The nitro group can be reduced to an amine, which can alter the compound's pharmacokinetic properties and bioavailability. This reactivity makes 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid a valuable building block for further chemical modifications.

In recent years, there has been growing interest in developing novel compounds with fluorine-containing aromatic rings due to their ability to enhance metabolic stability, binding affinity, and pharmacological activity. The combination of a fluorophenyl group with a nitro-substituted benzoic acid moiety creates a complex molecular structure that may exhibit unique interactions with biological receptors. Such structural features are particularly relevant in the design of small-molecule drugs targeting neurological disorders, cancer, and inflammatory conditions.

Current research in medicinal chemistry has highlighted the importance of multi-target directed ligands, which are designed to interact with multiple biological targets simultaneously. The structural features of 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid make it a promising candidate for such applications. For instance, the carboxy group can interact with acidic proteases or receptors, while the fluorophenyl and nitro groups may engage with hydrophobic pockets or redox-active sites. This dual functionality could lead to synergistic effects in therapeutic intervention.

One notable area of investigation involves the use of nitroaromatic compounds as inhibitors of enzyme activity. The nitro group can serve as a reversible inhibitor by reacting with reactive cysteine residues in enzymes, leading to covalent binding or conformational changes that modulate enzyme function. Studies have shown that nitroaromatic derivatives can exhibit potent inhibitory effects against various enzymes implicated in metabolic diseases and cancer progression. The presence of both a carboxy group and a fluorophenyl substituent in 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid may enhance its binding affinity and selectivity for specific enzyme targets.

The pharmaceutical industry has also explored the use of fluorinated benzoic acids as intermediates in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents. The fluorine atom can improve drug stability by inhibiting metabolic degradation pathways such as cytochrome P450-mediated oxidation. Additionally, fluorinated aromatic rings often enhance lipophilicity, which can improve oral bioavailability and tissue penetration. These properties make 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid a valuable precursor for developing novel therapeutics with improved pharmacokinetic profiles.

In conclusion, 3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid (CAS No: 1261898-31-0) represents a structurally complex and functionally versatile compound with significant potential in pharmaceutical research. Its unique combination of functional groups—namely, the carboxylic acid, nitro group, and fluorophenyl moiety—makes it an attractive candidate for drug discovery efforts targeting neurological disorders, cancer, inflammation, and other diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 14027-75-9(3-Fluoro-5-nitrobenzoic acid)
• 1261962-57-5(3-(3-Fluoro-2-methylphenyl)-5-nitrobenzoic acid)
• 1261968-85-7(2-Fluoro-4-(3-nitrophenyl)benzoic acid)
• 223767-02-0(2-(4-Fluorophenyl)-4-nitrobenzoic acid)
• 1261970-42-6(2'-Fluoro-4'-methyl-5-nitro-[1,1'-biphenyl]-3-carboxylic acid)
• 1214350-57-8(2-(3-fluorophenyl)-4-nitrobenzoic acid)
• 1261890-15-6(2-(5-Fluoro-2-methylphenyl)-4-nitrobenzoic acid)
• 1261991-29-0(3-(2,5-Difluorophenyl)-5-nitrobenzoic acid)
• 1214381-81-3(3'-Fluoro-5-nitro[1,1'-biphenyl]-3-carboxylic acid)
• 1261964-43-5(3-Fluoro-4-(3-nitrophenyl)benzoic acid)